1. Hootman JM, Brault MW, Helmick CG, Theis KA, Armour BS. Prevalence and most common causes of disability among adults United States, 2005. Morbidity and Mortality Weekly Report. 2009;58:421–426. [PubMed]
2. Praemer A, Furner S, Rice DP. Musculoskeletal Conditions in the United States. American Academy of Orthopaedic Surgeons; Rosemont, IL: 1999.
3. Goldring MB. Update on the biology of the chondrocyte and new approaches to treating cartilage diseases. Best Pract Res Clin Rheumatol. 2006;20:1003–25. [PubMed]
4. Jackson DW, Simon TM, Aberman HM. Symptomatic articular cartilage degeneration: the impact in the new millennium. Clin Orthop Relat Res. 2001:S14–25. [PubMed]
5. Rotter N, Haisch A, Bucheler M. Cartilage and bone tissue engineering for reconstructive head and neck surgery. Eur Arch Otorhinolaryngol. 2005;262:539–45. [PubMed]
6. Langer R, Vacanti JP. Tissue engineering. Science. 1993;260:920–6. [PubMed]
7. Aichroth PM, Patel DV, Moyes ST. A prospective review of arthroscopic debridement for degenerative joint disease of the knee. Int Orthop. 1991;15:351–5. [PubMed]
8. Aubin PP, Cheah HK, Davis AM, Gross AE. Long-term followup of fresh femoral osteochondral allografts for posttraumatic knee defects. Clin Orthop Relat Res. 2001:S318–27. [PubMed]
9. Baumgaertner MR, Cannon WD, Jr, Vittori JM, Schmidt ES, Maurer RC. Arthroscopic debridement of the arthritic knee. Clin Orthop Relat Res. 1990:197–202. [PubMed]
10. Denoncourt PM, Patel D, Dimakopoulos P. Arthroscopy update #1. Treatment of osteochondrosis dissecans of the knee by arthroscopic curettage, follow-up study. Orthop Rev. 1986;15:652–7. [PubMed]
11. Emmerson BC, et al. Fresh osteochondral allografting in the treatment of osteochondritis dissecans of the femoral condyle. Am J Sports Med. 2007;35:907–14. [PubMed]
12. Friedman MJ, Berasi CC, Fox JM. Preliminary results with abrasion arthroplasty in the osteoarthritic knee. Clinical Orthopaedics and Related Research NO. 1984;182:200–205.
13. Ghazavi MT, Pritzker KP, Davis AM, Gross AE. Fresh osteochondral allografts for post-traumatic osteochondral defects of the knee. J Bone Joint Surg Br. 1997;79:1008–13. [PubMed]
14. Johnson LL. Arthroscopic abrasion arthroplasty: a review. Clin Orthop Relat Res. 2001:S306–17.[PubMed]
15. Kish G, Modis L, Hangody L. Osteochondral mosaicplasty for the treatment of focal chondral and osteochondral lesions of the knee and talus in the athlete. Rationale, indications, techniques, and results.Clin Sports Med. 1999;18:45–66. vi. [PubMed]
16. Steadman JR, et al. Outcomes of microfracture for traumatic chondral defects of the knee: average 11-year follow-up. Arthroscopy. 2003;19:477–84. [PubMed]
17. Steadman JR, Rodkey WG, Rodrigo JJ. Microfracture: surgical technique and rehabilitation to treat chondral defects. Clin Orthop Relat Res. 2001:S362–9. [PubMed]
18. Nehrer S, Spector M, Minas T. Histologic analysis of tissue after failed cartilage repair procedures.Clin Orthop Relat Res. 1999:149–62. [PubMed]
19. Shapiro F, Koide S, Glimcher MJ. Cell origin and differentiation in the repair of full-thickness defects of articular cartilage. J Bone Joint Surg Am. 1993;75:532–53. [PubMed]
20. Tew SR, Kwan AP, Hann A, Thomson BM, Archer CW. The reactions of articular cartilage to experimental wounding: role of apoptosis. Arthritis Rheum. 2000;43:215–25. [PubMed]
21. Breinan HA, et al. Effect of cultured autologous chondrocytes on repair of chondral defects in a canine model. J Bone Joint Surg Am. 1997;79:1439–51. [PubMed]
22. Brittberg M, et al. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med. 1994;331:889–95. [PubMed]
23. Knutsen G, et al. Autologous chondrocyte implantation compared with microfracture in the knee. A randomized trial. J Bone Joint Surg Am. 2004;86-A:455–64. [PubMed]
24. Lee CR, Grodzinsky AJ, Hsu HP, Martin SD, Spector M. Effects of harvest and selected cartilage repair procedures on the physical and biochemical properties of articular cartilage in the canine knee.Journal of Orthopaedic Research. 2000;18:790–799. [PubMed]
25. Thirion S, Berenbaum F. Culture and phenotyping of chondrocytes in primary culture. Methods Mol Med. 2004;100:1–14. [PubMed]
26. Stokes DG, et al. Assessment of the gene expression profile of differentiated and dedifferentiated human fetal chondrocytes by microarray analysis. Arthritis Rheum. 2002;46:404–19. [PubMed]
27. Ohara K, Nakamura K, Ohta E. Chest wall deformities and thoracic scoliosis after costal cartilage graft harvesting. Plast Reconstr Surg. 1997;99:1030–6. [PubMed]
28. Chang SC, Tobias G, Roy AK, Vacanti CA, Bonassar LJ. Tissue engineering of autologous cartilage for craniofacial reconstruction by injection molding. Plast Reconstr Surg. 2003;112:793–9. discussion 800-1. [PubMed]
29. Caplan AI, Bruder SP. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med. 2001;7:259–64. [PubMed]
30. Owen M, Friedenstein AJ. Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found Symp. 1988;136:42–60. [PubMed]
31. Pittenger MF, et al. Multilineage potential of adult human mesenchymal stem cells. Science.1999;284:143–7. [PubMed]
32. Aust L, et al. Yield of human adipose-derived adult stem cells from liposuction aspirates.Cytotherapy. 2004;6:7–14. [PubMed]
33. Gimble JM, Guilak F. Differentiation potential of adipose derived adult stem (ADAS) cells. Curr Top Dev Biol. 2003;58:137–60. [PubMed]
34. Awad HA, Halvorsen YD, Gimble JM, Guilak F. Effects of transforming growth factor beta1 and dexamethasone on the growth and chondrogenic differentiation of adipose-derived stromal cells. Tissue Eng. 2003;9:1301–12. [PubMed]
35. Awad HA, Wickham MQ, Leddy HA, Gimble JM, Guilak F. Chondrogenic differentiation of adipose-derived adult stem cells in agarose, alginate, and gelatin scaffolds. Biomaterials. 2004;25:3211–22.[PubMed]
36. Erickson GR, et al. Chondrogenic potential of adipose tissue-derived stromal cells in vitro and in vivo. Biochem Biophys Res Commun. 2002;290:763–9. [PubMed]
37. Guilak F, et al. Clonal analysis of the differentiation potential of human adipose-derived adult stem cells. J Cell Physiol. 2006;206:229–37. [PubMed]
38. Halvorsen YC, Wilkison WO, Gimble JM. Adipose-derived stromal cells–their utility and potential in bone formation. Int J Obes Relat Metab Disord. 2000;24 (Suppl 4):S41–4. [PubMed]
39. Huang CY, Reuben PM, D’Ippolito G, Schiller PC, Cheung HS. Chondrogenesis of human bone marrow-derived mesenchymal stem cells in agarose culture. Anat Rec A Discov Mol Cell Evol Biol.2004;278:428–36. [PubMed]
40. Safford KM, et al. Neurogenic differentiation of murine and human adipose-derived stromal cells.Biochem Biophys Res Commun. 2002;294:371–9. [PubMed]
41. Wickham MQ, Erickson GR, Gimble JM, Vail TP, Guilak F. Multipotent stromal cells derived from the infrapatellar fat pad of the knee. Clin Orthop Relat Res. 2003:196–212. [PubMed]
42. Zuk PA, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell.2002;13:4279–95. [PMC free article] [PubMed]
43. Zuk PA, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies.Tissue Eng. 2001;7:211–28. [PubMed]
44. Wang DW, Fermor B, Gimble JM, Awad HA, Guilak F. Influence of oxygen on the proliferation and metabolism of adipose derived adult stem cells. J Cell Physiol. 2005;204:184–91. [PubMed]
45. Estes BT, Wu AW, Guilak F. Potent induction of chondrocytic differentiation of human adipose-derived adult stem cells by bone morphogenetic protein 6. Arthritis Rheum. 2006;54:1222–32.[PubMed]
46. Oedayrajsingh-Varma MJ, et al. Adipose tissue-derived mesenchymal stem cell yield and growth characteristics are affected by the tissue-harvesting procedure. Cytotherapy. 2006;8:166–77. [PubMed]
47. Estes BT, Diekman BO, Guilak F. Monolayer cell expansion conditions affect the chondrogenic potential of adipose-derived stem cells. Biotechnol Bioeng. 2008;99:986–95. [PubMed]
48. Hennig T, et al. Reduced chondrogenic potential of adipose tissue derived stromal cells correlates with an altered TGFbeta receptor and BMP profile and is overcome by BMP-6. J Cell Physiol.2007;211:682–91. [PubMed]
49. Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res. 1998;238:265–72. [PubMed]
50. Cheng NC, Estes BT, Awad HA, Guilak F. Chondrogenic Differentiation of Adipose-Derived Adult Stem Cells by a Porous Scaffold Derived from Native Articular Cartilage Extracellular Matrix. Tissue Engineering Part A. 2009;15:231–241. [PubMed]
51. Diekman BO, Rowland CR, Caplan AI, Lennon D, Guilak F. Chondrogenesis of adult stem cells from adipose tissue and bone marrow: Induction by growth factors and cartilage derived matrix. Tissue Eng Part A. 2009 doi: 10.1089/ten.TEA.2009.0398. [Cross Ref]
52. Guilak F, Hung CT. In: Basic Orthopaedic Biomechanics and Mechano-Biology. Mow VC, Huiskes R, editors. Lippincott Williams & Wilkins; Philadelphia: 2004.
53. Mow VC, Guo XE. Mechano-electrochemical properties of articular cartilage: their inhomogeneities and anisotropies. Annu Rev Biomed Eng. 2002;4:175–209. [PubMed]
54. Mow VC, Proctor CS, Kelly MA. In: Basic Biomechanics of the Musculoskeletal System. Nordin M, Frankel VH, editors. Lea & Febiger; Philadelphia, London: 1989. pp. 31–58.
55. Heinegård D, Oldberg A. Structure and biology of cartilage and bone matrix noncollagenous macromolecules. FASEB Journal. 1989;3:2042–51. [PubMed]
56. Diekman BO, Estes BT, Guilak F. The effects of BMP6 overexpression on adipose stem cell chondrogenesis: Interactions with dexamethasone and exogenous growth factors. J Biomed Mater Res A. 2009 doi: 10.1002/jbm.a.32589. [Cross Ref]
57. Estes BT, Wu AW, Storms RW, Guilak F. Extended passaging, but not aldehyde dehydrogenase activity, increases the chondrogenic potential of human adipose-derived adult stem cells. J Cell Physiol.2006;209:987–95. [PubMed]
58. Pilgaard L, et al. Effect of oxygen concentration, culture format and donor variability on in vitro chondrogenesis of human adipose tissue-derived stem cells. Regen Med. 2009;4:539–48. [PubMed]
59. Vidal MA, et al. Comparison of chondrogenic potential in equine mesenchymal stromal cells derived from adipose tissue and bone marrow. Vet Surg. 2008;37:713–24. [PMC free article] [PubMed]
60. Mehlhorn AT, et al. Differential effects of BMP-2 and TGF-beta1 on chondrogenic differentiation of adipose derived stem cells. Cell Prolif. 2007;40:809–23. [PubMed]
61. Guilak F, et al. Control of stem cell fate by physical interactions with the extracellular matrix. Cell Stem Cell. 2009;5:17–26. [PMC free article] [PubMed]
62. Moutos FT, Freed LE, Guilak F. A biomimetic three-dimensional woven composite scaffold for functional tissue engineering of cartilage. Nat Mater. 2007;6:162–7. [PubMed]
63. Lefebvre V, Huang W, Harley VR, Goodfellow PN, de Crombrugghe B. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol. 1997;17:2336–46.[PMC free article] [PubMed]
64. Neidert MR, Lee ES, Oegema TR, Tranquillo RT. Enhanced fibrin remodeling in vitro with TGF-beta1, insulin and plasmin for improved tissue-equivalents. Biomaterials. 2002;23:3717–31. [PubMed]
65. Stegemann H, Stalder K. Determination of hydroxyproline. Clin Chim Acta. 1967;18:267–73.[PubMed]
66. Hollander AP, et al. Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J Clin Invest. 1994;93:1722–32. [PMC free article] [PubMed]
67. Nolan T, Hands RE, Bustin SA. Quantification of mRNA using real-time RT-PCR. Nat Protoc.2006;1:1559–82. [PubMed]